Agenda & Council Documents

← Back to Page
OPEN SESSION – May 19, 2011 – 8:30 a.m.
Scheduled Event Speaker Supporting Documents
8:30 a.m. I. Call to Order and Opening Remarks Dr. Linda Birnbaum  
  II. Review of Confidentiality and Conflict of Interest Dr. Gwen Collman  
  III. Consideration of February 2011 Meeting Minutes Dr. Gwen Collman
8:45 a.m. IV. Report of the Director, NIEHS Dr. Linda Birnbaum
9:45 a.m. V. Strategic Plan Process Dr. Rick Woychik  
10:15 a.m. Break    
10:30 a.m. VI. The NIEHS Human Research Protection Program Dr. Joan Packenham
11:45 am Lunch    
1:00 pm. VII. Permanent Reprogramming of Gene Expression in Response to Neonatal Phytoestrogen Exposure: Implications for Female Reproductive Tract Function and Pathology Dr. Carmen Williams
2:00 p.m. VIII. Report of the Director, DERT
Appeals Policy
Dr. Gwen Collman
Dr. Pat Mastin
2:45 p.m. Break    
3:00 p.m. IX. Update on NIEHS/DERT Epigenetics/Epigenomics Activities Dr. Fred Tyson  
3:45 p.m. X. NIEHS Investments in Autism: An Update Dr. Cindy Lawler  
4:30 p.m. XI. In Small Doses: Arsenic (Dartmouth Video) Dr. William Suk  
4:45 p.m. XII. Adjournment    
OPEN SESSION - May 20, 2011 - 8:30 a.m.
8:30 a.m. XIII. Concept Clearance: An Integrated, Multi-Institute Plan to Facilitate Gene-Environment Interaction Studies Drs. David Balshaw, Kim McAllister, Dan Shaughnessy
9:15 a.m. XIV. Global Climate Change and Sustainability: NIEHS Efforts to Integrate Human Health Dr. John Balbus  
9:45 a.m. Break    
CLOSED SESSION 1
10:00 a.m. XV. Consideration of Grant Applications Dr. Gwen Collman and DERT staff  
12:00 p.m. XVI. Adjournment    

Additional Meeting Materials

Future Meeting Dates

  • September 1-2, 2011 - NIEHS
  • February 15-16, 2012 - NIEHS
  • May 21-23, 2012 - NIEHS
  • September 11-12, 2012 - NIEHS

1 This portion of the meeting is being closed to the public in accordance with the provisions set forth in Section 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).